WeVote
Log In

Bill

Bill

HB 1262

Patient Access to Compounded Medical Items

2026 Regular Session

HB 1262 establishes Colorado patient access requirements for compounded medical items, affecting pharmacy practices and insurance coverage for specialized prescriptions.

Governor Signed
#healthcare&healthinsurance #professions&occupations
0
WeVote Research Nonpartisan
Bill Summary · HB 1262

Legislative bill overview

HB 1262 establishes requirements for patient access to compounded medical items in Colorado, likely addressing pharmacy compounding practices and patient protections. The bill has been recently introduced and assigned to the Health & Human Services committee for consideration. The specific provisions are not yet publicly detailed given its early stage in the legislative process.

Why is this important

Compounded medications and medical items serve patients with specialized needs—including those with allergies, dosage requirements, or conditions where commercially available products are inadequate. Clear access regulations affect healthcare costs, patient safety, and the availability of treatments for vulnerable populations. This bill could impact how Colorado regulates pharmacy compounding and what patients can obtain.

Potential points of contention

  • Scope of coverage: Whether insurance must cover compounded items versus commercial alternatives, and cost implications for insurers and patients
  • Quality and safety standards: How strictly compounded items must be regulated, potentially affecting smaller compounding pharmacies versus larger operations
  • Insurance reimbursement vs. patient access: Balancing affordability for patients against ensuring compounders maintain proper standards and don't substitute for inadequate commercial market oversight

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.